Catalent, which was acquired by Novo Nordisk in December, is a leading contract drug manufacturer operating over 30 manufacturing facilities in the U.S. and abroad. The company makes hundreds of ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

A bipartisan report warned Congress about China’s growing control over the pharmaceutical supply chain. Elsewhere, Alkermes sweetened its bid for Avadel and Moderna is investing $140 million in U.S.

Three out of four adults in the United States live with conditions that can increase the risk of severe illness. 9 Chronic ...

With the greater part of third quarter earnings results in the rearview mirror, investors are looking ahead to marquee ...

A new trial is to take place at 10 UK locations involving patients diagnosed with multiple sclerosis (MS). It is set to investigate whether a vaccine designed to protect against a common virus found ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

A new trial will test whether a jab to protect against a common virus found in almost all people with multiple sclerosis (MS) ...

The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...

Nearly two dozen life sciences companies that were awarded Massachusetts tax incentives to create and retain about 1,000 ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...